Surrozen (SRZN) director receives 5,550 stock options at $30.14 strike price

Rhea-AI Filing Summary

Surrozen, Inc. director Eric Bjerkholt received a grant of stock options covering 5,550 shares of common stock. The options have an exercise price of $30.14 per share and expire in 2036. According to the terms, they vest and become exercisable on the anniversary of the grant date, subject to his continuous service as a director.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BJERKHOLT ERIC

Role null

Type	Security	Shares	Price	Value
Grant/Award	Director Stock Option (right to buy)	5,550	$0.00	--

Holdings After Transaction: Director Stock Option (right to buy) — 5,550 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 5,550 shares Exercise price: $30.14 per share Total options after grant: 5,550 options +1 more

4 metrics

Option grant size 5,550 shares Director stock option grant covering common stock

Exercise price $30.14 per share Exercise price for director stock options

Total options after grant 5,550 options Total derivative holdings following transaction

Expiration date May 12, 2036 Option term end date

Key Terms

Director Stock Option, exercise price, expiration date, Grant, award, or other acquisition

4 terms

Director Stock Option financial

"security_title: "Director Stock Option (right to buy)""

exercise price financial

"conversion_or_exercise_price: "30.1400""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: "2036-05-12T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BJERKHOLT ERIC

(Last) (First) (Middle)

C/O SURROZEN, INC.

171 OYSTER POINT BLVD., SUITE 400

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Surrozen, Inc./DE [ SRZN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (right to buy)	$30.14	05/13/2026		A		5,550		05/13/2027(1)	05/12/2036	Common Stock	5,550	$0	5,550	D

Explanation of Responses:

1. The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director.

	/s/ Charles Williams, Attorney-in-Fact for Eric Bjerkholt	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Surrozen (SRZN) disclose in this Form 4 for director Eric Bjerkholt?

Surrozen reported that director Eric Bjerkholt received a grant of options for 5,550 shares of common stock. The options were awarded at an exercise price of $30.14 per share as compensation, increasing his derivative holdings in the company.

How many Surrozen (SRZN) shares are covered by the new stock option grant?

The new grant covers options for 5,550 shares of Surrozen common stock. These director stock options give the right to buy that many shares at a fixed exercise price if and when they vest and are exercised in the future.

What is the exercise price of the Surrozen (SRZN) options granted to the director?

The options granted to director Eric Bjerkholt have an exercise price of $30.14 per share. This means he can purchase Surrozen common stock at that price once the options vest and he chooses to exercise them.

When do the Surrozen (SRZN) director stock options vest and become exercisable?

The options vest and become exercisable on the anniversary of the grant date. Vesting is subject to Eric Bjerkholt’s continuous service as a director, so he must remain on the board through that anniversary for the options to vest.

When do the Surrozen (SRZN) stock options granted to the director expire?

The director stock options expire on May 12, 2036. If they are not exercised by that expiration date, they will lapse, and the right to purchase Surrozen common shares under this grant will be lost.

How many Surrozen (SRZN) options does the director hold after this transaction?

After this grant, Eric Bjerkholt holds 5,550 director stock options directly. This total reflects the derivative position reported in the Form 4, all tied to Surrozen common stock under the newly awarded option grant.